BAL cells analysis and lung function parameters in fibrotic hypersensitivity pneumonitis at baseline and in relation
Punchalee Kaenmuang1, Fiammetta Danzo2, Simon Bax3
1Interstitial Lung Disease Unit, Royal Brompton Hospital, Guy's and St Thomas' National Health Service Foundation Trust, London, SW3 6NP, United Kingdom; Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, London, SW3 6LY, United Kingdom; Respiratory and Respiratory Critical Care Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla, 90110, Thailand.
Abstract:
In fibrotic hypersensitivity pneumonitis, the relevance of bronchoalveolar lavage (BAL) lymphocytosis remains unclear. We investigated the relationship between BAL %lymphocytes, baseline pulmonary function tests (PFTs) and transplant-free survival. We retrospectively analysed 162 treatment-naïve patients (median age 64 years; 43 % male; 39 % ever-smokers) undergoing BAL within three months of PFTs. Mean FVC 79 %, DLCO 43 %, composite physiologic index (CPI) 48. Median BAL lymphocytes were 24 %(IQR 21-28). BAL %lymphocytes were associated with less severe disease, FVC [coefficient 0.28 (95 %C.I. 0.06-0.48), p = 0.01], FEV1 [0.20(0.0002-0.41), p = 0.05], and CPI [-0.11(-0.21 to -0.01, p = 0.04]. Although BAL% lymphocytes were not correlated with DLCO, significant opposite correlations were observed for its two components: positive with VA% [0.32 (0.18-0.45), p < 0.0005]; negative with KCO% [-0.37(-0.51 to -0.23), p < 0.0005]. In adjusted Cox regression models, BAL %lymphocytes, lower CPI, higher %FVC, %FEV1 and %DLCO were significantly associated with increased survival. These findings suggest BAL lymphocytosis reflects a pathophysiological pattern linked to better outcomes.
More Related Videos
06:29Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Published on: May 5, 2023
03:38Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
Published on: June 20, 2025
